Free Trial
NASDAQ:SLS

SELLAS Life Sciences Group (SLS) Stock Price, News & Analysis

SELLAS Life Sciences Group logo
$2.17 +0.06 (+2.59%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$2.17 0.00 (-0.18%)
As of 07/3/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SELLAS Life Sciences Group Stock (NASDAQ:SLS)

Key Stats

Today's Range
$2.12
$2.20
50-Day Range
$1.41
$2.19
52-Week Range
$0.77
$2.27
Volume
1.40 million shs
Average Volume
1.72 million shs
Market Capitalization
$217.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SELLAS Life Sciences Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

SLS MarketRank™: 

SELLAS Life Sciences Group scored higher than 3% of companies evaluated by MarketBeat, and ranked 925th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for SELLAS Life Sciences Group.

  • Earnings Growth

    Earnings for SELLAS Life Sciences Group are expected to grow in the coming year, from ($0.57) to ($0.42) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of SELLAS Life Sciences Group is -5.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of SELLAS Life Sciences Group is -5.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    SELLAS Life Sciences Group has a P/B Ratio of 16.73. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about SELLAS Life Sciences Group's valuation and earnings.
  • Percentage of Shares Shorted

    19.21% of the float of SELLAS Life Sciences Group has been sold short.
  • Short Interest Ratio / Days to Cover

    SELLAS Life Sciences Group has a short interest ratio ("days to cover") of 8.6.
  • Change versus previous month

    Short interest in SELLAS Life Sciences Group has recently increased by 54.66%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    SELLAS Life Sciences Group does not currently pay a dividend.

  • Dividend Growth

    SELLAS Life Sciences Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.21% of the float of SELLAS Life Sciences Group has been sold short.
  • Short Interest Ratio / Days to Cover

    SELLAS Life Sciences Group has a short interest ratio ("days to cover") of 8.6.
  • Change versus previous month

    Short interest in SELLAS Life Sciences Group has recently increased by 54.66%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 4 people have searched for SLS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added SELLAS Life Sciences Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SELLAS Life Sciences Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $48,600.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.40% of the stock of SELLAS Life Sciences Group is held by insiders.

  • Percentage Held by Institutions

    Only 17.38% of the stock of SELLAS Life Sciences Group is held by institutions.

  • Read more about SELLAS Life Sciences Group's insider trading history.
Receive SLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter.

SLS Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
Sellas Life Sciences: Tons Of Completed Studies
See More Headlines

SLS Stock Analysis - Frequently Asked Questions

SELLAS Life Sciences Group's stock was trading at $1.04 at the beginning of 2025. Since then, SLS stock has increased by 109.1% and is now trading at $2.1750.

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) posted its earnings results on Tuesday, May, 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.04.

SELLAS Life Sciences Group shares reverse split on the morning of Friday, November 8th 2019.The 1-50 reverse split was announced on Wednesday, November 6th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of SLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SELLAS Life Sciences Group investors own include (UNISQ) (UNISQ), Amgen (AMGN), Generex Biotechnology (GNBT), Salesforce (CRM), Bank of America (BAC), Bristol Myers Squibb (BMY) and AbbVie (ABBV).

Company Calendar

Last Earnings
5/13/2025
Today
7/05/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLS
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1 million
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
16.73

Miscellaneous

Free Float
98,380,000
Market Cap
$217.02 million
Optionable
Not Optionable
Beta
2.31
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SLS) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners